Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 71851-71900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06097962
Safety and Efficacy of NK510 to Treat NSCLC
EARLY_PHASE1Recruiting
9 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT05796427
"Testing SupporT for ADHD and Related Treatment (START) for Families of Children With ADHD"
NAActive, not recruiting
106 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05833594
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
N/ARecruiting
70 participants
Started: Jul 1, 2023 · Completed: Dec 1, 2026
4 conditions1 sponsor1 location
NCT05342740
Study of Biomarkers in Diabetic Chronic Wounds
N/ARecruiting
930 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05436860
PreDEA Study, Prevention in Emergency / Acceptance Departments: the Case of Hepatic Steatosis
N/ARecruiting
20,189 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2024
1 condition1 sponsor1 location
NCT05886712
Improving Access to Naloxone to Prevent Opioid Overdose Deaths (SAIA-Naloxone)
NAActive, not recruiting
31 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT06495034
Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema
NARecruiting
132 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05875675
Effects of Pioglitazone in Calcific Aortic Valve Disease
PHASE2Not yet recruiting
100 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2028
2 conditions1 sponsor0 locations
NCT05849974
Large Cohort of 1000 Patients With Severe Myopia
NANot yet recruiting
1,000 participants
Started: Jun 30, 2023 · Completed: May 31, 2038
1 condition2 sponsors0 locations
NCT05968742
Variation in Gingival Inflammatory Responses
NARecruiting
80 participants
Started: Jun 30, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT04316650
Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia
NANot yet recruiting
250 participants
Started: Jun 30, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05877768
Evaluation of PCD-CT Based Image Parameters in the Assessment and Quantification of Coronary Artery Disease
N/ANot yet recruiting
3,000 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2033
1 condition1 sponsor1 location
NCT05925049
A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)
N/AActive, not recruiting
400 participants
Started: Jun 30, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05702502
Assessing the Presence of CT-DNA in Lymphoma Associated HLH
N/ARecruiting
12 participants
Started: Jun 30, 2023 · Completed: Jan 1, 2026
2 conditions1 sponsor1 location
NCT05631912
TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL
PHASE1/PHASE2Recruiting
38 participants
Started: Jun 30, 2023 · Completed: Dec 15, 2025
1 condition1 sponsor2 locations
NCT05940233
Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone
NARecruiting
70 participants
Started: Jun 30, 2023 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT05800899
Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities Among Latinxs
NARecruiting
600 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2027
1 condition4 sponsors1 location
NCT05824494
Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
PHASE2Not yet recruiting
58 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2026
6 conditions2 sponsors0 locations
NCT05607121
TMS Visual Modulation in Body Dysmorphic Disorder
NARecruiting
40 participants
Started: Jun 30, 2023 · Completed: Oct 1, 2025
1 condition2 sponsors1 location
NCT06638723
Enhancing Motor Function in Individuals with Lower Limb Amputation
NARecruiting
20 participants
Started: Jun 30, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05870475
Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV
PHASE2Recruiting
94 participants
Started: Jun 30, 2023 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05600881
Towards an Understanding of the Mechanism of Action of Methylphenidate in ADHD
N/ANot yet recruiting
35 participants
Started: Jun 30, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors0 locations
NCT04704141
Relationship of the Microenvironment and Male Fertility
N/ANot yet recruiting
150 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05519579
Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia
PHASE2Recruiting
20 participants
Started: Jun 30, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06174597
Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy
EARLY_PHASE1Recruiting
40 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05915351
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)
PHASE2Active, not recruiting
28 participants
Started: Jun 30, 2023 · Completed: Jun 1, 2026
3 conditions1 sponsor1 location
NCT06012461
Closed-loop DBS in Parkinson's Disease
NARecruiting
10 participants
Started: Jun 30, 2023 · Completed: Dec 30, 2025
1 condition5 sponsors1 location
NCT05504837
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
PHASE1Recruiting
12 participants
Started: Jun 30, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor5 locations
NCT05917600
Impact of Advanced Practical Nursing Intervention Versus Usual Care on Hypertension Control
NANot yet recruiting
330 participants
Started: Jun 30, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05660733
Study of the Aortic and Large Arterial Vessel Infections
N/ARecruiting
500 participants
Started: Jun 30, 2023 · Completed: Jan 1, 2027
4 conditions1 sponsor1 location
NCT06120296
Hypotension Prediction Index for Shoulder Surgery in Beach Chair.
NARecruiting
144 participants
Started: Jun 30, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05836350
Role of BCAA in Glucose Homeostasis
PHASE4Not yet recruiting
20 participants
Started: Jun 30, 2023 · Completed: May 31, 2026
1 condition1 sponsor0 locations
NCT04983251
Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity
N/ARecruiting
700 participants
Started: Jun 30, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05913141
PDO/PDO-TIL/PDOTS for Drug Screen
N/ARecruiting
30 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05865496
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
PHASE2Active, not recruiting
90 participants
Started: Jun 30, 2023 · Completed: Jul 31, 2024
3 conditions1 sponsor4 locations
NCT06922162
Tickle Stimulation in Disorders of Consciousness (DoC)
N/ARecruiting
45 participants
Started: Jun 30, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT05738057
Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
PHASE2Recruiting
22 participants
Started: Jun 30, 2023 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT05744154
Reducing Low-value Care for Trauma Admissions
NANot yet recruiting
29 participants
Started: Jun 30, 2023 · Completed: Dec 31, 2026
1 condition7 sponsors1 location
NCT05741073
Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC
N/ARecruiting
1,300 participants
Started: Jun 30, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT03838302
Evaluation of Sexual Functions With Validated Measurement Scale After Transvaginal Extraction of Tissue by Laparoscopic Surgery With Uterus Preservation (FSF-TVE)
N/ANot yet recruiting
40 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05919095
A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer
PHASE2Not yet recruiting
37 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05890430
Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation
N/ANot yet recruiting
570 participants
Started: Jun 30, 2023 · Completed: Jul 31, 2033
4 conditions1 sponsor0 locations
NCT05793372
Hyperhomocysteinemia in Alzheimer's Disease
N/ANot yet recruiting
43 participants
Started: Jun 30, 2023 · Completed: Mar 1, 2026
2 conditions1 sponsor0 locations
NCT06047028
'Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability
N/ARecruiting
30 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05502016
Family Model DSME in FBOs in the RMI
NARecruiting
288 participants
Started: Jun 30, 2023 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT05387694
Study of the Prognostic Value of the Coagulolytic Balance Dependent on Circulating Microvesicles in the Occurrence of Thrombotic Events After Total Knee Replacement in Orthopedic Surgery.
NANot yet recruiting
387 participants
Started: Jun 30, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05663710
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC
PHASE1/PHASE2Recruiting
100 participants
Started: Jun 30, 2023 · Completed: Oct 30, 2027
2 conditions3 sponsors1 location
NCT05925192
Profile of Chronic Musculoskeletal Pain Patients Related to Treatment Adherence and Virtual Reality
N/ARecruiting
100 participants
Started: Jun 30, 2023 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05830760
Expression of Sodium-glucose Co-transporter 2 in Human Heart
NANot yet recruiting
80 participants
Started: Jun 30, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06894290
International Cardiac Amyloidosis Registry
N/ARecruiting
300 participants
Started: Jun 30, 2023 · Completed: Jul 31, 2026
1 condition2 sponsors6 locations